Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Epidemiology

Value of Examining Three Acid-Fast Bacillus Sputum Smears for Removal of Patients Suspected of Having Tuberculosis from the “Airborne Precautions” Category

David W. Craft, Melissa C. Jones, Cherie N. Blanchet, Roy L. Hopfer
David W. Craft
Clinical Microbiology and Immunology Laboratories, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melissa C. Jones
Clinical Microbiology and Immunology Laboratories, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cherie N. Blanchet
Hospital Epidemiology, University of North Carolina Hospitals, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roy L. Hopfer
Clinical Microbiology and Immunology Laboratories, and
Departments of Microbiology and Immunology and of Pathology and Laboratory Medicine,University of North Carolina, Chapel Hill, North Carolina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.38.11.4285-4287.2000
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

We examined the potential risk of tuberculosis transmission if we modified our policy for release of patients from the “airborne precautions” category from three negative acid-fast bacillus (AFB) smears to two, or even one. Over a 4-year period, respiratory cultures from 42 patients grew Mycobacterium tuberculosis. Of these, 36 patients (81%) had a positive AFB smear result on the first submitted specimen. One additional patient (2%) had a first smear-positive finding on the second submitted specimen, and no patients had a first smear-positive result on the third submitted specimen. Respiratory cultures from five patients (12%) grew M. tuberculosis without ever having a positive AFB smear result. These data indicate that in our institution, reducing the number of negative smears required before removal of patients from the airborne precautions category would pose little, if any, increase in the risk of spreading tuberculosis.

Health care facilities are required to adhere to Occupational Safety and Health Administration guidelines and Centers for Disease Control and Prevention recommendations for preventing the transmission of tuberculosis to employees or patients (1). Under these guidelines, patients suspected of having pulmonary tuberculosis are placed in and remain in the “airborne precautions” category until discharge, until another diagnosis is made, or until a determination has been made that the patient is noninfectious. A number of community-based studies have demonstrated that a single variable, the acid-fast bacillus (AFB) smear status of the source case, strongly predicts which patients are the most contagious (8, 9). Current hospital infection control policy requires three negative AFB sputum smears, obtained on three separate days, before a patient may be removed from the airborne precautions category. At our institution, nontuberculosis isolates account for nearly 90% of positive smears. We examined the potential risk of tuberculosis transmission if we modified our policy for release from airborne precautions from three negative smears to two, or even one. We then compared the costs associated with the current policy to those of the two modifications by determining procedures billable to the patient for potentially unnecessary days spent under airborne precautions.

We reviewed the last 4 years of mycobacteriology laboratory data from all patients with expectorated or induced sputum specimens yielding growth of Mycobacterium tuberculosis. Specimens were processed, concentrated, examined microscopically, and inoculated by standard methods (4). First smear-positive specimens were amplified with the Eisenach IS1660 primers, which are specific forM. tuberculosis (2). When appropriate, cultures were probed by AccuProbe (Gen-Probe, San Diego, Calif.) for the presence of the M. tuberculosis complex, theMycobacterium avium-M. intracellulare complex,Mycobacterium kansasii, or Mycobacterium gordonae. Identification of other mycobacteria was accomplished by conventional biochemical testing.

Of 42 patients with sputum cultures that grew M. tuberculosis, 36 (81%) had a positive AFB smear result from the first specimen submitted. One additional patient (2%) had the first smear-positive finding on the second submitted specimen. There were no tuberculosis patients that were smear positive on the third smear only. Five (12%) patient sputum cultures grew M. tuberculosiswithout ever having had a positive AFB smear result (three or more negative smears).

Table 1 demonstrates the potential transmission of M. tuberculosis based on the policy adopted. Under current policy, five tuberculosis patients that never had a smear-positive result were considered potential transmission risks. If the policy had been modified (modification 1) to two negative smears before release from the airborne precautions category, there would have been no change in the number of potential transmission risk patients. If the policy had been modified further (modification 2), to only one negative smear before release, one smear-positive patient (total of 6) would have been released, posing a potential increase in the risk of transmission to others.

View this table:
  • View inline
  • View popup
Table 1.

Policy impact on release from the “airborne precautions” category for 42 patients with culture-positive pulmonary tuberculosisa

Based on data collected the first 4 months of 1999 (data not shown), our institution would be expected to place around 360 patients into the airborne precautions category each year. Of these, 270 will have ≥3 negative AFB smears, the vast majority remaining culture negative for AFB. Approximately 40 of these smear-negative patients will become AFB culture positive, with 1 or at most 2 yielding M. tuberculosis. The remaining 90 patients will be AFB smear positive on the first or second smear. If modification 1 were implemented in our institution, we could expect about 270 fewer patient days under airborne precautions, resulting in a $32,000 decrease in patient charges (based on $120/day). Similarly, using modification 2, the decrease in patient charges for 540 fewer patient days under airborne precautions would be $65,000. This potential savings would have to be weighed against the increased costs associated with an additional postexposure workup.

Airborne transmission of tuberculosis is a public health concern. It has been estimated that 10 secondary infections arise annually from 1 untreated smear-positive case of tuberculosis (11). In the United States, only 50 to 60% of patients with pulmonary tuberculosis will have a positive sputum smear (1). Even with the combined sensitivity of three smears, approximately 4 of 10 patients with pulmonary tuberculosis will go undetected until cultures become positive for growth. However, the AFB smear-based approach to isolation has proven successful in interrupting nosocomial outbreaks of tuberculosis (3, 5, 7, 8). The AFB smear is a cheap and rapid test compared to culture for identifying highly infectious persons.

At a minimum, the examination of at least one sputum specimen is necessary to predict the infectivity of patients suspected of tuberculosis. Nelson et al. showed that the diagnostic value of a second specimen is considerable, improving the overall sensitivity of culture by nearly 30% regardless of smear result (6). Yet the same study showed that only 5% of tuberculosis patients were smear positive on the third or subsequent specimen, leading the authors to conclude that rarely is a third specimen of diagnostic value. Similarly, Cascina et al. found the sensitivity of culture increased by 16% with the second specimen and by another 8% with the third specimen (A. Cascina, A. Fietta, and L. Casali, Letter, J. Clin. Microbiol. 38:466, 2000).

Our study differs from these earlier reports in that we were interested in determining the value of first, second, and third AFB smear results in deciding whether to remove a patient from the airborne precautions category. Interestingly, in our institution, the sensitivity of the first smear was higher (82%) than in the earlier reports (73 and 72%, respectively). In addition, M. tuberculosis was grown from the first specimen for all smear-positive samples and from the first specimen from 5 of the 6 patients with a smear-negative finding in our institution. Our data indicate that in our institution 12% of patients with pulmonary tuberculosis will have three or more negative smears. The percentage remains the same if the criterion for release is decreased from three negative smears to two. Exposure risks would presumably be low since smear-negative, culture-positive specimens result from decreased numbers of viable organisms in respiratory secretions. In our study we had five culture-positive patients with three or more negative AFB smears, indicating that multiple cultures are needed to detect M. tuberculosis in smear-negative (paucibacillary) patients. One patient had a positive smear finding on the second sputum specimen submitted, which was read as 1+, indicating low numbers in the final specimen. There was never a negative smear followed by a 2+ or 3+ result. Therefore, patients with tuberculosis that produce smear-negative sputa tend to remain low shedders unless some significant clinical change occurs. Clinical judgment is a more important criterion for submitting additional AFB specimens than the fact that the patient has already had one or even three previous negative smears. Similar strategies have been indicated for removing culture-positive tuberculosis patients from the airborne precautions category during antimycobacterial therapy. Telzak et al. suggested that treated patients could be removed from isolation after only two consecutive negative smears without significantly increasing the risk of person-to-person transmission (12).

It is important to reduce hospital expenses such as those generated by unnecessary placement of patients under airborne precautions, while at the same time insuring that the risk of transmission to other patients or health care workers is not increased. Our calculations are based on savings to the patient due to earlier removal from the airborne precautions category. Other cost variables not analyzed include early removal due to another diagnosis, delayed removal because sputum specimens are not submitted on a daily basis, and increased costs associated with a tuberculosis exposure workup. Lastly, our cost analysis does not take into account the increased difficulty of providing health care to an individual under airborne precautions. Regardless of the exact amount of savings that might be generated, our data suggest that a change in policy from three to two negative smears before release (modification 1) would not cause an identifiable risk of spreading tuberculosis in our institution. In fact, modification 1 would have no impact on detection of the five smear-negative (≥3 negative smears), culture-positive tuberculosis patients identified during the course of the study.

The current University of North Carolina hospital infection control policy requires three negative AFB smears, with each specimen obtained at least 24 h apart, before a patient is released from the application of airborne precautions. Our study suggests that modifying the smear policy from three to two negative smears would result in no increased risk of spreading tuberculosis and would decrease the number of days patients are unnecessarily placed under airborne precautions. In addition, patients would realize a decrease in billable charges related to days spent under airborne precautions. Clinical judgment as to whether a patient has pulmonary tuberculosis, not the number of negative AFB smears, should determine whether a patient could be removed from the airborne precautions category.

FOOTNOTES

    • Received 19 May 2000.
    • Returned for modification 8 July 2000.
    • Accepted 28 August 2000.
  • Copyright © 2000 American Society for Microbiology

REFERENCES

  1. 1.↵
    Centers for Disease Control and Prevention Guidelines for preventing the transmission of Mycobacterium tuberculosis in health care facilities.Morbid. Mortal. Weekly Rep.43RR-1319941132
    OpenUrl
  2. 2.↵
    1. Eisenach K.,
    2. Cave M.,
    3. Bates J.,
    4. Crawford J.
    Polymerase chain reaction amplification of a repetitive sequence specific for Mycobacterium tuberculosis.J. Infect. Dis.1611990977981
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Gordin F.,
    2. Slutkin G.
    The validity of acid-fast smears in the diagnosis of tuberculosis.Arch. Pathol. Lab. Med.114199010251027
    OpenUrlPubMedWeb of Science
  4. 4.↵
    1. Kent B. D.,
    2. Kubica G. P.
    Public health mycobacteriology: a guide for the level III laboratory. 1985 Centers for Disease Control Atlanta, Ga
  5. 5.↵
    1. Marraro R. V.,
    2. Rodgers E. M.,
    3. Roberts T. H.
    The acid-fast smear: fact or fiction? J. Am. Med. Technol. 37 1975 277 279
    OpenUrl
  6. 6.↵
    1. Nelson S. M.,
    2. Deike M. A.,
    3. Cartwright C. P.
    Value of examining multiple sputum specimens in the diagnosis of pulmonary tuberculosis.J. Clin. Microbiol.361998467469
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Rickman T. W.,
    2. Moyer N. P.
    Increased sensitivity of acid-fast smears.J. Clin. Microbiol.111980618620
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Sepkowitz K. A.
    How contagious is tuberculosis? Clin. Infect. Dis. 23 1996 954 962
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Shinnick T. M.,
    2. Good R. C.
    Diagnostic mycobacteriology laboratory practices.Clin. Infect. Dis.211995291299
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.
    1. Sommers H. M.,
    2. McClatchy J. K.
    Cumitech 16 1983Laboratory diagnosis of the mycobacterioses. Coordinating ed., J. A. Morello. American Society for Microbiology, Washington, D.C.
  11. 11.↵
    1. Stylbo K.
    Etat actuel de la question: epidemiologie de la tuberculose.Bull. Int. Union Tuberc.5319785366
    OpenUrl
  12. 12.↵
    1. Telzak E. E.,
    2. Fazal B. A.,
    3. Pollard C. L.,
    4. et al.
    Factors influencing time to sputum conversion among patients with smear-positive pulmonary tuberculosis.Clin. Infect. Dis.251997666670
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Download PDF
Citation Tools
Value of Examining Three Acid-Fast Bacillus Sputum Smears for Removal of Patients Suspected of Having Tuberculosis from the “Airborne Precautions” Category
David W. Craft, Melissa C. Jones, Cherie N. Blanchet, Roy L. Hopfer
Journal of Clinical Microbiology Nov 2000, 38 (11) 4285-4287; DOI: 10.1128/JCM.38.11.4285-4287.2000

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Value of Examining Three Acid-Fast Bacillus Sputum Smears for Removal of Patients Suspected of Having Tuberculosis from the “Airborne Precautions” Category
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Value of Examining Three Acid-Fast Bacillus Sputum Smears for Removal of Patients Suspected of Having Tuberculosis from the “Airborne Precautions” Category
David W. Craft, Melissa C. Jones, Cherie N. Blanchet, Roy L. Hopfer
Journal of Clinical Microbiology Nov 2000, 38 (11) 4285-4287; DOI: 10.1128/JCM.38.11.4285-4287.2000
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X